Clinical trial
Cinacalcet to Treat Familial Primary Hyperparathyroidism
NCT00325104 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00325104 |
|---|---|
| Title | Cinacalcet to Treat Familial Primary Hyperparathyroidism |
| Official title | Cinacalcet Actions in Familial Primary Hyperparathyroidism |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercalcemia, Familial Primary Hyperparathyroidism |
| Intervention type | Procedure |
| Interventions | Parathyroid hormone testing, Serum calcium testing |
| Enrollment | 25 |
| Start date | May 9, 2006 |
| Completion | Mar 31, 2007 |
| First posted | May 12, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: